Cure My Disease

Don't miss your cure!

 Log in / Sign up

Numbing patch eases injection pain for trigger finger sufferers

NCT ID NCT05032508

Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether applying a Xylocaine (numbing) compress before a trigger finger injection reduces pain during the procedure. 60 adults with trigger finger took part in a double-blind trial where neither they nor the doctor knew who got the numbing compress. The main goal was to measure pain levels during the injection using a 0-100 scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

60 people

The number who actually took part.

Started

Jun 2022

Finished

Jun 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years or older * Trigger Finger (clinically defined by painful difficulty or protrusion when extending the finger) with an ultrasound-guided infiltration of cortisone derivatives indication. * Written consent * Affiliation to a Social Security system * Prior medical examination Exclusion Criteria: * Neurological conditions affecting the hand other than carpal tunnel syndrome * Intra-articular infiltration of the hand or the wrist ≤ 2 months * Allergy to Xylocaine * Contraindication to Xylocaine or cortisone derivatives * Cognitive or behavioral disorders that make assessment impossible * Persons referred to in articles L 1121-5; 6; 8; 9 of the Public Health Code (protected adults, under guardianship or curatorship, etc) * Pregnancy and breastfeeding; absence of contraceptive method for women of childbearing age * Participant unable to speak, read and write French

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Trigger finger are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

trigger thumb

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Trigger finger

Contacts and locations

Locations

  • Cochin hospital

    Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.